Global Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Gene Therapy Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gene Therapy Drugs industry chain, the market status of Hospital (Neuromuscular Disease, Genetic Disease), Pharmacy (Neuromuscular Disease, Genetic Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy Drugs.

Regionally, the report analyzes the Gene Therapy Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gene Therapy Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Neuromuscular Disease, Genetic Disease).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy Drugs market.

Regional Analysis: The report involves examining the Gene Therapy Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gene Therapy Drugs:
Company Analysis: Report covers individual Gene Therapy Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Gene Therapy Drugs. It assesses the current state, advancements, and potential future developments in Gene Therapy Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Neuromuscular Disease
    Genetic Disease
    Other

Market segment by Application
    Hospital
    Pharmacy

Market segment by players, this report covers
    F. Hoffmann-La Roche AG
    Novartis International AG
    Gilead Sciences, Inc.
    Ultragenyx Pharmaceutical，Inc.
    Applied Genetic Technologies Corp
    Audentes Therapeutics
    BioMarin Pharmaceutical
    Bluebird Bio
    Nightstar Therapeutics
    Sangamo Therapeutics
    Spark Therapeutics
    uniQure
    VBL Therapeutics
    Voyager Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy Drugs, with revenue, gross margin and global market share of Gene Therapy Drugs from 2019 to 2024.
Chapter 3, the Gene Therapy Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy Drugs.
Chapter 13, to describe Gene Therapy Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy Drugs by Type
        1.3.1 Overview: Global Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gene Therapy Drugs Consumption Value Market Share by Type in 2023
        1.3.3 Neuromuscular Disease
        1.3.4 Genetic Disease
        1.3.5 Other
    1.4 Global Gene Therapy Drugs Market by Application
        1.4.1 Overview: Global Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Pharmacy
    1.5 Global Gene Therapy Drugs Market Size & Forecast
    1.6 Global Gene Therapy Drugs Market Size and Forecast by Region
        1.6.1 Global Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gene Therapy Drugs Market Size by Region, (2019-2030)
        1.6.3 North America Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.4 Europe Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.6 South America Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gene Therapy Drugs Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 F. Hoffmann-La Roche AG
        2.1.1 F. Hoffmann-La Roche AG Details
        2.1.2 F. Hoffmann-La Roche AG Major Business
        2.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Solutions
        2.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
    2.2 Novartis International AG
        2.2.1 Novartis International AG Details
        2.2.2 Novartis International AG Major Business
        2.2.3 Novartis International AG Gene Therapy Drugs Product and Solutions
        2.2.4 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis International AG Recent Developments and Future Plans
    2.3 Gilead Sciences, Inc.
        2.3.1 Gilead Sciences, Inc. Details
        2.3.2 Gilead Sciences, Inc. Major Business
        2.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Product and Solutions
        2.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Gilead Sciences, Inc. Recent Developments and Future Plans
    2.4 Ultragenyx Pharmaceutical，Inc.
        2.4.1 Ultragenyx Pharmaceutical，Inc. Details
        2.4.2 Ultragenyx Pharmaceutical，Inc. Major Business
        2.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Solutions
        2.4.4 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments and Future Plans
    2.5 Applied Genetic Technologies Corp
        2.5.1 Applied Genetic Technologies Corp Details
        2.5.2 Applied Genetic Technologies Corp Major Business
        2.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Product and Solutions
        2.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Applied Genetic Technologies Corp Recent Developments and Future Plans
    2.6 Audentes Therapeutics
        2.6.1 Audentes Therapeutics Details
        2.6.2 Audentes Therapeutics Major Business
        2.6.3 Audentes Therapeutics Gene Therapy Drugs Product and Solutions
        2.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Audentes Therapeutics Recent Developments and Future Plans
    2.7 BioMarin Pharmaceutical
        2.7.1 BioMarin Pharmaceutical Details
        2.7.2 BioMarin Pharmaceutical Major Business
        2.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Product and Solutions
        2.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 BioMarin Pharmaceutical Recent Developments and Future Plans
    2.8 Bluebird Bio
        2.8.1 Bluebird Bio Details
        2.8.2 Bluebird Bio Major Business
        2.8.3 Bluebird Bio Gene Therapy Drugs Product and Solutions
        2.8.4 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Bluebird Bio Recent Developments and Future Plans
    2.9 Nightstar Therapeutics
        2.9.1 Nightstar Therapeutics Details
        2.9.2 Nightstar Therapeutics Major Business
        2.9.3 Nightstar Therapeutics Gene Therapy Drugs Product and Solutions
        2.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Nightstar Therapeutics Recent Developments and Future Plans
    2.10 Sangamo Therapeutics
        2.10.1 Sangamo Therapeutics Details
        2.10.2 Sangamo Therapeutics Major Business
        2.10.3 Sangamo Therapeutics Gene Therapy Drugs Product and Solutions
        2.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Sangamo Therapeutics Recent Developments and Future Plans
    2.11 Spark Therapeutics
        2.11.1 Spark Therapeutics Details
        2.11.2 Spark Therapeutics Major Business
        2.11.3 Spark Therapeutics Gene Therapy Drugs Product and Solutions
        2.11.4 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Spark Therapeutics Recent Developments and Future Plans
    2.12 uniQure
        2.12.1 uniQure Details
        2.12.2 uniQure Major Business
        2.12.3 uniQure Gene Therapy Drugs Product and Solutions
        2.12.4 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 uniQure Recent Developments and Future Plans
    2.13 VBL Therapeutics
        2.13.1 VBL Therapeutics Details
        2.13.2 VBL Therapeutics Major Business
        2.13.3 VBL Therapeutics Gene Therapy Drugs Product and Solutions
        2.13.4 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 VBL Therapeutics Recent Developments and Future Plans
    2.14 Voyager Therapeutics
        2.14.1 Voyager Therapeutics Details
        2.14.2 Voyager Therapeutics Major Business
        2.14.3 Voyager Therapeutics Gene Therapy Drugs Product and Solutions
        2.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Voyager Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy Drugs Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gene Therapy Drugs by Company Revenue
        3.2.2 Top 3 Gene Therapy Drugs Players Market Share in 2023
        3.2.3 Top 6 Gene Therapy Drugs Players Market Share in 2023
    3.3 Gene Therapy Drugs Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy Drugs Market: Region Footprint
        3.3.2 Gene Therapy Drugs Market: Company Product Type Footprint
        3.3.3 Gene Therapy Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gene Therapy Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gene Therapy Drugs Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gene Therapy Drugs Consumption Value by Type (2019-2030)
    6.2 North America Gene Therapy Drugs Consumption Value by Application (2019-2030)
    6.3 North America Gene Therapy Drugs Market Size by Country
        6.3.1 North America Gene Therapy Drugs Consumption Value by Country (2019-2030)
        6.3.2 United States Gene Therapy Drugs Market Size and Forecast (2019-2030)
        6.3.3 Canada Gene Therapy Drugs Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gene Therapy Drugs Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gene Therapy Drugs Consumption Value by Type (2019-2030)
    7.2 Europe Gene Therapy Drugs Consumption Value by Application (2019-2030)
    7.3 Europe Gene Therapy Drugs Market Size by Country
        7.3.1 Europe Gene Therapy Drugs Consumption Value by Country (2019-2030)
        7.3.2 Germany Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.3 France Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.5 Russia Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.6 Italy Gene Therapy Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy Drugs Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gene Therapy Drugs Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gene Therapy Drugs Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy Drugs Consumption Value by Region (2019-2030)
        8.3.2 China Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.3 Japan Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.5 India Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.7 Australia Gene Therapy Drugs Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gene Therapy Drugs Consumption Value by Type (2019-2030)
    9.2 South America Gene Therapy Drugs Consumption Value by Application (2019-2030)
    9.3 South America Gene Therapy Drugs Market Size by Country
        9.3.1 South America Gene Therapy Drugs Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gene Therapy Drugs Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gene Therapy Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy Drugs Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gene Therapy Drugs Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gene Therapy Drugs Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy Drugs Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gene Therapy Drugs Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gene Therapy Drugs Market Size and Forecast (2019-2030)
        10.3.4 UAE Gene Therapy Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gene Therapy Drugs Market Drivers
    11.2 Gene Therapy Drugs Market Restraints
    11.3 Gene Therapy Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gene Therapy Drugs Industry Chain
    12.2 Gene Therapy Drugs Upstream Analysis
    12.3 Gene Therapy Drugs Midstream Analysis
    12.4 Gene Therapy Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
    Table 6. F. Hoffmann-La Roche AG Major Business
    Table 7. F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Solutions
    Table 8. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. F. Hoffmann-La Roche AG Recent Developments and Future Plans
    Table 10. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 11. Novartis International AG Major Business
    Table 12. Novartis International AG Gene Therapy Drugs Product and Solutions
    Table 13. Novartis International AG Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis International AG Recent Developments and Future Plans
    Table 15. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
    Table 16. Gilead Sciences, Inc. Major Business
    Table 17. Gilead Sciences, Inc. Gene Therapy Drugs Product and Solutions
    Table 18. Gilead Sciences, Inc. Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Gilead Sciences, Inc. Recent Developments and Future Plans
    Table 20. Ultragenyx Pharmaceutical，Inc. Company Information, Head Office, and Major Competitors
    Table 21. Ultragenyx Pharmaceutical，Inc. Major Business
    Table 22. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Solutions
    Table 23. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Ultragenyx Pharmaceutical，Inc. Recent Developments and Future Plans
    Table 25. Applied Genetic Technologies Corp Company Information, Head Office, and Major Competitors
    Table 26. Applied Genetic Technologies Corp Major Business
    Table 27. Applied Genetic Technologies Corp Gene Therapy Drugs Product and Solutions
    Table 28. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Applied Genetic Technologies Corp Recent Developments and Future Plans
    Table 30. Audentes Therapeutics Company Information, Head Office, and Major Competitors
    Table 31. Audentes Therapeutics Major Business
    Table 32. Audentes Therapeutics Gene Therapy Drugs Product and Solutions
    Table 33. Audentes Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Audentes Therapeutics Recent Developments and Future Plans
    Table 35. BioMarin Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 36. BioMarin Pharmaceutical Major Business
    Table 37. BioMarin Pharmaceutical Gene Therapy Drugs Product and Solutions
    Table 38. BioMarin Pharmaceutical Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. BioMarin Pharmaceutical Recent Developments and Future Plans
    Table 40. Bluebird Bio Company Information, Head Office, and Major Competitors
    Table 41. Bluebird Bio Major Business
    Table 42. Bluebird Bio Gene Therapy Drugs Product and Solutions
    Table 43. Bluebird Bio Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Bluebird Bio Recent Developments and Future Plans
    Table 45. Nightstar Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Nightstar Therapeutics Major Business
    Table 47. Nightstar Therapeutics Gene Therapy Drugs Product and Solutions
    Table 48. Nightstar Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Nightstar Therapeutics Recent Developments and Future Plans
    Table 50. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
    Table 51. Sangamo Therapeutics Major Business
    Table 52. Sangamo Therapeutics Gene Therapy Drugs Product and Solutions
    Table 53. Sangamo Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Sangamo Therapeutics Recent Developments and Future Plans
    Table 55. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 56. Spark Therapeutics Major Business
    Table 57. Spark Therapeutics Gene Therapy Drugs Product and Solutions
    Table 58. Spark Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Spark Therapeutics Recent Developments and Future Plans
    Table 60. uniQure Company Information, Head Office, and Major Competitors
    Table 61. uniQure Major Business
    Table 62. uniQure Gene Therapy Drugs Product and Solutions
    Table 63. uniQure Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. uniQure Recent Developments and Future Plans
    Table 65. VBL Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. VBL Therapeutics Major Business
    Table 67. VBL Therapeutics Gene Therapy Drugs Product and Solutions
    Table 68. VBL Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. VBL Therapeutics Recent Developments and Future Plans
    Table 70. Voyager Therapeutics Company Information, Head Office, and Major Competitors
    Table 71. Voyager Therapeutics Major Business
    Table 72. Voyager Therapeutics Gene Therapy Drugs Product and Solutions
    Table 73. Voyager Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Voyager Therapeutics Recent Developments and Future Plans
    Table 75. Global Gene Therapy Drugs Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Gene Therapy Drugs Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Gene Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Gene Therapy Drugs Players
    Table 80. Gene Therapy Drugs Market: Company Product Type Footprint
    Table 81. Gene Therapy Drugs Market: Company Product Application Footprint
    Table 82. Gene Therapy Drugs New Market Entrants and Barriers to Market Entry
    Table 83. Gene Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Gene Therapy Drugs Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
    Table 86. Global Gene Therapy Drugs Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Gene Therapy Drugs Consumption Value by Application (2019-2024)
    Table 88. Global Gene Therapy Drugs Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Gene Therapy Drugs Raw Material
    Table 120. Key Suppliers of Gene Therapy Drugs Raw Materials
List of Figures
    Figure 1. Gene Therapy Drugs Picture
    Figure 2. Global Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gene Therapy Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Neuromuscular Disease
    Figure 5. Genetic Disease
    Figure 6. Other
    Figure 7. Global Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Gene Therapy Drugs Consumption Value Market Share by Application in 2023
    Figure 9. Hospital Picture
    Figure 10. Pharmacy Picture
    Figure 11. Global Gene Therapy Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Gene Therapy Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Gene Therapy Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Gene Therapy Drugs Consumption Value Market Share by Region in 2023
    Figure 16. North America Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Gene Therapy Drugs Revenue Share by Players in 2023
    Figure 22. Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Gene Therapy Drugs Market Share in 2023
    Figure 24. Global Top 6 Players Gene Therapy Drugs Market Share in 2023
    Figure 25. Global Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
    Figure 26. Global Gene Therapy Drugs Market Share Forecast by Type (2025-2030)
    Figure 27. Global Gene Therapy Drugs Consumption Value Share by Application (2019-2024)
    Figure 28. Global Gene Therapy Drugs Market Share Forecast by Application (2025-2030)
    Figure 29. North America Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 63. Gene Therapy Drugs Market Drivers
    Figure 64. Gene Therapy Drugs Market Restraints
    Figure 65. Gene Therapy Drugs Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Gene Therapy Drugs in 2023
    Figure 68. Manufacturing Process Analysis of Gene Therapy Drugs
    Figure 69. Gene Therapy Drugs Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics